2nd Quarter - Report

CROSSROADS STRATEGIES, LLC for EISAI, INC.

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Part D Medicare Program including coverage for obesity medications. Proposed Part B IPI Demonstration Project. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, State Health Care Premium Reduction Act. H.R.748, CARES Act (P.L.116-136) implementation.

LobbyistCovered position, as disclosed
KATHERINE DAPPER —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 748 (116th), S. 2543 (116th), H.R. 1425 (116th), H.R. 19 (116th), H.R. 3 (116th)

Health Issues HCR

Regulatory and legislative health care issues including the 340B program, the TRICARE Pharmacy Program, and pharmaceutical supply chain. Implementation of the Chronic Care Act of 2017. FDA Guidance on Alzheimer's drug development. H.R.6395/S.4049, National Defense Authorization Act for Fiscal Year 2021. H.R.6482/S.3537/S.3635, Protecting Our Pharmaceutical Supply Chain from China Act of 2020. H.R.6431, Made in America Emergency Preparedness Act.

LobbyistCovered position, as disclosed
KATHERINE DAPPER —
STEWART HALL —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6395 (116th), S. 4049 (116th), S. 3537 (116th), S. 3635 (116th), H.R. 6482 (116th), H.R. 6431 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.